Betaloc 25 mg. 30 tablets

$18.00

Hypertension and heart failure

SKU: 667 Category:

Description

BETALOC 25 MG (1X30)

Indications

Betaloc 25 mg, containing the active ingredient metoprolol, is primarily indicated for the treatment of hypertension (high blood pressure). It is also used in the management of angina pectoris (chest pain due to reduced blood flow to the heart) and for the prevention of myocardial infarction (heart attack). Additionally, Betaloc is indicated for the treatment of heart failure and for the management of arrhythmias (irregular heartbeats). Its efficacy in these conditions makes it a valuable medication in cardiovascular therapy.

Mechanism of Action

Metoprolol is a selective beta-1 adrenergic receptor blocker. By blocking the action of catecholamines (such as adrenaline) on beta-1 receptors predominantly located in the heart, metoprolol reduces heart rate, myocardial contractility, and conduction velocity through the atrioventricular node. This action results in decreased cardiac output and lower blood pressure, which is beneficial in treating hypertension and reducing the workload on the heart. Furthermore, by decreasing heart rate and contractility, metoprolol helps to alleviate symptoms of angina and improve exercise tolerance in patients with coronary artery disease.

Pharmacological Properties

Metoprolol is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 1 to 2 hours after oral administration. It has a bioavailability of about 50% due to first-pass metabolism in the liver. The drug is extensively metabolized in the liver, primarily by cytochrome P450 2D6, and has a half-life of approximately 3 to 7 hours, which may vary among individuals. Metoprolol is excreted mainly in the urine as metabolites, with less than 5% of the dose excreted unchanged. The pharmacokinetics of metoprolol can be influenced by factors such as age, liver function, and concomitant medications.

Contraindications

Betaloc 25 mg is contraindicated in patients with known hypersensitivity to metoprolol or any of its components. It should not be used in individuals with severe bradycardia (slow heart rate), second or third-degree heart block, cardiogenic shock, or overt heart failure. Additionally, patients with a history of asthma or severe chronic obstructive pulmonary disease (COPD) should use this medication with caution, as beta-blockers can potentially exacerbate bronchospasm. It is also contraindicated in patients with severe peripheral arterial disease.

Side Effects

Common side effects of Betaloc may include fatigue, dizziness, depression, and gastrointestinal disturbances such as nausea or diarrhea. Some patients may experience bradycardia, hypotension, or cold extremities due to decreased blood flow. Rare but serious side effects include severe allergic reactions, worsening of heart failure, and signs of liver dysfunction. Patients should be advised to report any unusual or severe symptoms to their healthcare provider promptly.

Dosage and Administration

The usual starting dose of Betaloc for adults with hypertension is 25 mg once daily, which may be adjusted based on individual response and blood pressure readings. For angina, the initial dose may also be 25 mg, with potential titration to a maximum of 100 mg per day, depending on the clinical situation. In patients with heart failure, the dosing should be initiated at a lower dose and gradually increased under close supervision. It is important to take Betaloc with or immediately after food to enhance absorption and minimize gastrointestinal side effects. Patients should be instructed to adhere to the prescribed dosage and not to discontinue the medication abruptly without consulting their healthcare provider.

Interactions

Metoprolol can interact with several medications, which may alter its effectiveness or increase the risk of adverse effects. Concomitant use of other antihypertensive agents, such as diuretics or calcium channel blockers, may lead to additive effects on blood pressure, necessitating careful monitoring. Non-steroidal anti-inflammatory drugs (NSAIDs) can reduce the antihypertensive effect of metoprolol. Additionally, medications that affect liver enzymes, particularly CYP2D6 inhibitors (e.g., fluoxetine, paroxetine), can increase plasma levels of metoprolol, leading to enhanced effects and potential toxicity. It is essential for patients to inform their healthcare provider about all medications, including over-the-counter drugs and supplements, to avoid harmful interactions.

Precautions

Before initiating treatment with Betaloc, a thorough medical history and assessment of the patient’s cardiovascular status are necessary. Caution should be exercised in patients with a history of asthma, diabetes, or severe peripheral vascular disease. Regular monitoring of heart rate and blood pressure is recommended, especially during dose adjustments. In patients with diabetes, metoprolol may mask the symptoms of hypoglycemia, necessitating close monitoring of blood glucose levels. Abrupt discontinuation of Betaloc can lead to rebound hypertension or exacerbation of angina; therefore, any changes in therapy should be made gradually and under medical supervision.

Clinical Studies

Numerous clinical studies have demonstrated the efficacy of metoprolol in managing hypertension and reducing cardiovascular events. For instance, the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF) showed that metoprolol significantly reduced mortality and hospitalizations in patients with chronic heart failure. Other studies have confirmed its effectiveness in reducing the incidence of myocardial infarction and improving survival rates in patients with coronary artery disease. These findings underscore the importance of Betaloc in cardiovascular disease management and its role in improving patient outcomes.

Conclusion

Betaloc 25 mg is a well-established medication for the treatment of hypertension, angina, and heart failure. Its selective action on beta-1 adrenergic receptors makes it a valuable therapeutic option in managing various cardiovascular conditions. While generally well-tolerated, it is essential for patients to be aware of potential side effects and drug interactions. Proper dosing, monitoring, and patient education are crucial for optimizing treatment outcomes and ensuring safe use of this medication.

Important

It is essential to use Betaloc responsibly and under the guidance of a healthcare professional. Patients should adhere to prescribed dosages and report any adverse effects to their healthcare provider. Regular follow-ups and monitoring are important to ensure the safe and effective use of this medication.

Additional information

Weight 30 g